Transaction · 0001231919-26-001526

Ra Capital Management, L.P.

RA CAPITAL MANAGEMENT, L.P., 10%, reported an open-market or private sale at LENZ Therapeutics, Inc. involving 107170.000000 shares for an estimated $360091.20. Reported holdings after the transaction were 57559.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code S10%
LENZLENZ Therapeutics, Inc.
Trade date
Oct 29, 2026
Filing date
Nov 02, 2026
View on SEC Insider profile
Disclosed value-$360kShares × reported price
Shares traded107k$3.36 per share
Holdings after57.5kIndirect · See footnotes
% of reported position traded65.06%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 164,729 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

LENZ price since this filing

Daily closing prices, with the filing date and available return windows
LENZ · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +22.5%1w ago +3.2%1d ago +0.0%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001231919-26-001526
Common Stock
Transaction date
Oct 29, 2026
Filed Nov 02, 2026, 10:44 PM · 4d delay
Shares
107,170 sh
$3.36 per share
Estimated value
-$360k
Computed from shares × price
Holdings after
57,559 sh
Indirect · See footnotes

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Large Holdings Reduction Repeat Seller
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
    Read the scoring methodology

    Signed filing-only points, not a probability or expected return. Version v1.

    Reported relationships & other filings

    Form 4 relationship flags and nearby filing context

    Reported roles

    No officer title

    Officer NoDirector No10% YesOther No
    Footnotes & amended
    1. F1

      The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.16 to $3.58 inclusive. The Reporting Persons undertake to provide…

    2. F2

      RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus Fund II, L.P. (the "Nexus Fund II") and a separately managed a…

    3. F3

      Held directly by the Fund.

    4. F4

      Held directly by the Nexus Fund II.

    5. F5

      Held directly by the Account.

    Original filing · 0001231919-26-001526
    Related transactions

    0 other transactions

    Same SEC filing
    Recent company activity

    0 recent txs

    LENZ